The placenta at birth has recently been seen as a new source for cells in bone marrow replacement therapy in many diseases. (More? Stem Cells - Cord Blood)
Page Links: Introduction | Recent Findings | Molecular Trophoblast Development | Placenta Specific Genes | Terms | Glossary |References | About Notes |
Related Pages: Villi Development | Maternal Decidua | Placental Abnormalities | Stage 13/14 | Stage22 | Placental Histology | Placental Vascular Beds | Blood | Blood Vessels | Birth | Stem Cells - Cord Blood
SUMO-specific protease 2 is essential for modulating p53-Mdm2 in development of trophoblast stem cell niches and lineages. Chiu SY, Asai N, Costantini F, Hsu W. PLoS Biol. 2008 Dec 16;6(12):e310.
"SUMO-specific protease 2 (SENP2) modifies proteins by removing SUMO from its substrates. Although SUMO-specific proteases are known to reverse sumoylation in many defined systems, their importance in mammalian development and pathogenesis remains largely elusive. Here we report that SENP2 is highly expressed in (mouse) trophoblast cells that are required for placentation."
Trophoblast stem cell derivation, cross-species comparison and use of nuclear transfer: new tools to study trophoblast growth and differentiation. Rielland M, Hue I, Renard JP, Alice J. Dev Biol. 2008 Oct 1;322(1):1-10. Epub 2008 Jul 22. Review.
Model for the SENP2–Mdm2–p53 Pathway in Trophoblast Development
(A) Diagram illustrating the p53–Mdm2 circuit regulated by SENP2 in the trophoblast cell cycle. Stimulation of Mdm2 by SENP2 leads to degradation of p53. Cellular levels of p53 control the G–S transition that has a dual role in TGC development. The G–S phase is required for both mitotic division (cell cycle: G1, S, G2, and M) and endoreduplication (endocycle: G and S only) during expansion of trophoblast stem cells and maturation of trophoblasts, respectively. Although a low p53 level is essential for stem cell proliferation, inhibition of p53 is required upon differentiation.
(B) Schematic representation for the mechanism underlying the regulation of p53 and Mdm2 by the SUMO pathway. SENP2 activates Mdm2 by removing SUMO that permits the modulation of p53 by Mdm2 in the nucleus. The ubiquitin-conjugated p53 is then degraded in the cytoplasm.
From: SUMO-Specific Protease 2 Is Essential for Modulating p53-Mdm2 in Development of Trophoblast Stem Cell Niches and Lineages Chiu SY, Asai N, Costantini F, Hsu W PLoS Biology Vol. 6, No. 12, e310 doi:10.1371/journal.pbio.0060310
SUMO - Small Ubiquitin-like Modifier are a family of small proteins that modify the function of other proteins by covalently attaching to and detaching from the other proteins.
SUMOylation - a post-translational protein modification involving SUMO proteins and has a role in many different cellular processes.
placenta-specific genes: Tpbp, Plac1, Syncytin
retrotransposon-associated genes: Peg10, Rtl1, Endothelin B receptor, Insl4, Leptin, Midline1, and Pleiotrophin
enhancer elements: glycoprotein hormone alpha-subunit
gene isoforms: 3betaHSD, Cyp19
placenta-specific members of gene families: Gcm1, Mash2, Rhox, Esx1, Cathepsin, PAG, TKDP, Psg, Siglec
(Gene list from : The evolution, regulation, and function of placenta-specific genes. Rawn SM, Cross JC. Annu Rev Cell Dev Biol. 2008;24:159-81. Review)
Discoid in humans, mice, insectivores, rabbits, rats, and monkeys.
Zonary in dogs, cats, bears and seals.
Cotyledenary in cows, deer, goat, and giraffe.
Diffuse in horses, pigs, camels, lemurs, opossums, kangaroos, and whales.
(List modified from Dev Biology after Renfree, 1982 | four main types of placenta in different species)
Hemochorial placentas (maternal blood cells directly contacts fetal chorion) in humans, rats, and mice.
Endotheliochorial placentas (4 layer) in dogs, cats, seals, and ferrets.
Epitheliochorial placentas (6-layer) in pigs, cows, horses, and sheep.
(List modified from Dev Biology after Renfree, 1982 | cellular layers potentially between the fetal and maternal blood cells )
![]() |
Trophoblast cells are the major source of placental hormones. Placental growth hormone (PGH) is mainly expressed in the syncytiotrophoblast cells (PGH differs from pituitary derived growth hormone by 13 amino acids). extravillous cytotrophoblast - arise from anchoring villi invade the uterine spiral arteries, generating fibrinoid material and endovascular trophoblastic cells. syncytiotrophoblast |
![]() |
Fetal Blood Vessels At least 2 phases of development during pregnancy driven by vascular endothelial growth factor (VEGF):
|
![]() |
Fibrinoid - said to exist as 2 forms of extracellular matrix:
|
|
Endoreplication - rounds of nuclear DNA replication without intervening cell or nuclear division (mitosis). Cytokines - of maternal origin also act on placental development. Natural Killer (NK) cells - are present in the maternal decidua in large numbers close to the extravillous trophoblast cells. |
Maternal Decidual Cells are differentiated by progesterone from endometrial stromal cells (fibroblast-like). These cells change morphology (become enlarged and polygonal) and secrete various factors (prolactin, insulin-like growth factor binding protein-1, tissue factor, interleukin-15, and vascular endothelial growth factor).
Reviews
Articles
Search PubMed: Search term = placenta molecular development
A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z
